Home / Non‐Biological Complex Drugs

Non‐Biological Complex Drugs


Impax announces FDA approval of follow-on sevelamer carbonate posted 17/11/2017

US generics maker Impax Laboratories (Impax) announced on 23 October 2017 that it had received final US Food and Drug Adminis...


Biosimilars and follow-on NBCDs for MS in Europe, the US and Canada posted 19/01/2018

The advent of biological medicines has significantly transformed the landscapes of many disease spaces and improved the lives...


US guidelines for follow-on NBCDs posted 29/07/2016

The regulatory body for approval of medicines in the US is the Food and Drug Administration (FDA).

Polices & Legislation

FDA to set up abbreviated pathway for complex products posted 21/10/2016

As part of the Generic Drug User Fee Amendments (GDUFA II) reauthorization recently agreed with industry [1], the US Food and...


Equivalence of complex drug products posted 21/04/2017

Complex drug products and their generic (or follow-on) versions was the subject discussed at the New York Academy of Sciences...